Globus Medical is a medical device company located in Pennsylvania, United States, which is part of the Healthcare sector, and is traded under the ticker GMED on the NYSE exchange.
Globus Medical stock last closed at $74.35, down 2.98% from the previous day, and has increased 44.03% in one year. It has overperformed other stocks in the Medical Devices industry by 0.62 percentage points. Globus Medical stock is currently +50.72% from its 52-week low of $49.33, and -21.68% from its 52-week high of $94.93.
There are currently 137.54M GMED shares outstanding. The market value of GMED is $10.23B. In the last 24 hours, 1.03M GMED shares were traded.
How to Buy Globus Medical Stock
Wondering how to invest in Globus Medical stock? Here's how.
Choose where to buy Globus Medical stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you determine where to buy Globus Medical stock.
Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit money your investment account: Pick your payment method and add your info.
Research Globus Medical stock: The Globus Medical ticker symbol is GMED. Is Globus Medical stock a good investment? Should you buy shares of GMED? How do GMED's underlying business fundamentals look? Do top analysts think Globus Medical is a good buy? Why has GMED's stock price moved recently? (Hint: Our stock market research website can help you evaluate if GMED is a good stock to buy).
Make your GMED trade: Decide if you will purchase GMED shares at the current market price or use a limit order to purchase GMED shares at a particular price.
Keep an eye on your GMED position: Create a watchlist to get live updates on your new investment in Globus Medical shares.
Step 1: Choose where to buy Globus Medical stock
You need a brokerage account to access the NYSE market and buy GMED shares.
A brokerage account allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our research, eToro is the best place to buy stocks. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world financial markets: From Technology to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal information so you can buy GMED today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Globus Medical stock
Once you have decided on the best place to buy Globus Medical stock, it's critical to analyze their stock prior to investing, so you actually wrap your head around the risk as well as the upside.
Globus Medical stock at a glance
GMED Price
$74.35
1w %
1.38%
1y %
44.03%
5y %
72.51%
P/E
97.83x
P/B
2.45x
P/S
4.01x
PEG
0.84x
Revenue
$2.52B
Earnings
$102.98M
Fore. Rev. Growth
6.75%
Fore. Earn. Growth
128.97%
Market Cap
$10.23B
Next Earnings
May 5, 2025
Next Dividend
N/A
GMED Fundamentals
WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.
There are more short-term assets than short-term liabilities on the GMED balance sheet.
GMED earnings of $124.91M is not sufficient to cover its interest payments.
There are more short-term assets than long-term liabilities on the GMED balance sheet.
GMED's operating cash flow of $520.64M allows it to safely service it's debt of $537.19M.
GMED has a low debt to equity ratio of 0.26.
Cons:
Total GMED debt is higher than 5 years ago, relative to shareholder equity.
GMED profit margin has gone down from 7.8% to 4.1% in the past year.
Do analysts think it's a good time to buy Globus Medical stock
Out of 11 sell side analysts who give recommendations on GMED, the consensus analyst rating on Globus Medical is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Latest GMED Analyst Recommendations
Craig Bijou, a top 5% analyst from Bank of America upgrades GMED to a hold rating and raises their GMED price target from $80.00 to $97.00, on Jan 9, 2025.
Jason Wittes, a top 37% analyst from Roth MKM maintains GMED with a strong buy rating and raises their GMED price target from $100.00 to $115.00, on Dec 17, 2024.
Ryan Zimmerman, a top 7% analyst from BTIG maintains GMED with a strong buy rating and raises their GMED price target from $87.00 to $91.00, on Dec 12, 2024.
Drew Ranieri, a bottom 9% analyst from Morgan Stanley upgrades GMED to a strong buy rating and raises their GMED price target from $83.00 to $100.00, on Dec 2, 2024.
Shagun Singh, a top 28% analyst from RBC Capital maintains GMED with a buy rating and raises their GMED price target from $80.00 to $92.00, on Nov 6, 2024.
Last year, GMED earnings were $102.98M. During the past five year, GMED's earnings have grown by -13.51% per year. This was slower than the Medical Devices industry average of 9.64%.
Last year, GMED revenue was $2.52B. In the last 5 year, GMED's revenue has increased by 26.25% per year. This was faster than the Medical Devices industry average of 10.1%.
No, Globus Medical doesn't provide an income stream by paying out dividends.
What do other investors have to say about GMED?
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your GMED trade
There are two main order types:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are generally fine.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at an exact dollar amount limit, use a limit order.
Click the Open button and eToro will execute the order.
If you require additional assistance investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Globus Medical share?
As of Mar 26, 2025, it costs $74.35 to buy one share of Globus Medical stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.134 shares of GMED.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.